HIV

Gilead got a boost from a newly approved PrEP drug. Now, a major insurer is dropping coverage
MedCity News
Fri, 08/14/20 - 12:01 am
Gilead Sciences
UnitedHealthcare
PrEP
HIV
Descovy
Truvada
Moderna to open COVID-19 vaccine trials to people with HIV
Beckers Hospital Review
Sat, 08/8/20 - 10:52 pm
Moderna Therapeutics
clinical trials
mRNA-1273
vaccines
HIV
ViiV Healthcare gets FDA expanded approval for HIV-1 drug Dovato
Pharmaceutical Business Review
Fri, 08/7/20 - 10:40 am
ViiV Healthcare
FDA
HIV
Dovato
HIV-1
GSK’s latest pipeline review includes a slate of COPD programs headed to the scrap heap
Endpoints
Wed, 07/29/20 - 12:41 pm
GSK
R&D
COPD
HIV
cancer
CytoDyn shares slammed as BLA filing for leronlimab in HIV hits a wall
Endpoints
Mon, 07/13/20 - 12:17 pm
CytoDyn
leronlimab
HIV
FDA
After going ‘crazy’ over the science, Merck signs up a new partner in the hunt for an HIV cure
Endpoints
Mon, 07/13/20 - 11:09 am
Merck
Dewpoint Therapeutics
HIV
R&D
GSK sets the stage for a toe-to-toe market showdown with Gilead's HIV champion Truvada
Endpoints
Wed, 07/8/20 - 10:38 am
GSK
Gilead Sciences
ViiV Healthcare
HIV
cabotegravir
Truvada
GSK snags first-in-class FDA nod for Rukobia to treat HIV patients who have few options
Fierce Pharma
Tue, 07/7/20 - 10:37 am
GSK
ViiV Healthcare
Rukobia
fostemsavir
HIV
FDA
ViiV Healthcare gets FDA nod for HIV drug Rukobia to treat adult patients
Pharmaceutical Business Review
Fri, 07/3/20 - 01:05 pm
ViiV Healthcare
FDA
Rukobia
HIV
New Data Shows Promise Involving Lenacapavir for the Treatment of HIV
BioSpace
Thu, 07/2/20 - 11:30 pm
Gilead Sciences
lenacapavir
HIV
Experimental HIV drug seems effective at a twice-a-year dose, study finds
Stat
Wed, 07/1/20 - 11:25 am
HIV
Gilead Sciences
lenacapavir
clinical trials
Large UK study finds no benefit to HIV antiviral in COVID-19
BioPharma Dive
Tue, 06/30/20 - 11:31 pm
HIV
antivirals
COVID-19
pandemic
Kaletra
AbbVie
Merck’s Experimental Pneumonia Vaccine Hits the Mark in Two Phase III Studies
BioSpace
Mon, 06/22/20 - 08:38 pm
Merck
vaccines
V114
clinical trials
HIV
pneumonia
pneumococcal disease
Could Gilead Sciences Have an HIV Cure Waiting in the Wings?
Motley Fool
Sun, 06/14/20 - 10:49 pm
Gilead Sciences
HIV
bNab
Life-Saving HIV Drug PrEP On NHS Delayed Amid Coronavirus Pandemic
Forbes
Fri, 06/5/20 - 10:38 am
HIV
NHS
PrEP
pandemic
COVID-19
ImmunityBio’s Promising Preclinical HIV Drug is Moving into Phase I Trials
BioSpace
Thu, 05/21/20 - 11:11 pm
ImmunityBio
HIV
clinical trials
N-803
GSK sub’s injectable outperforms Gilead in late-stage PrEP trial
Endpoints
Tue, 05/19/20 - 10:33 am
GSK
Gilead Sciences
HIV
PrEP
Truvada
ViiV Healthcare
cabotegravir
More threat to Gilead's HIV business? GlaxoSmithKline touts long-acting injectable PrEP win against Truvada
Fierce Pharma
Mon, 05/18/20 - 11:12 am
GSK
Gilead Sciences
Truvada
cabotegravir
HIV
PrEP
Gilead charges CDC with contract breach on HIV research
Seeking Alpha
Sun, 04/26/20 - 08:31 pm
Gilead Sciences
CDC
patents
lawsuits
HIV
R&D
HIV And Flu Drugs Prove Futile In Fight Against Coronavirus
Forbes
Tue, 04/21/20 - 11:51 pm
China
clinical trials
HIV
Kaletra
Arbidol
COVID-19

Pages